Transparency Market Research presents this most up-to-date research on “Glaucoma Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024”
Glaucoma is a chronic, degenerative, permanent disorder whose rate increases essentially with age rather than causing immediate blindness. According to a survey of WHO, Glaucoma is the second most common cause of blindness affecting the population worldwide after cataract (47.9%). In general, Glaucoma occurs as after effects of increased intraocular pressure (IOP) brought about by an abnormality or malfunctioning of the eye drainage system. The normal IOP is in between the range of 19-21 inches of Hg but when the pressure exceed than this range, it causes compression of retina and optic nerve causing progressive, leading to permanent loss of visual perception if not treated on time. The most common types of glaucoma are open angle glaucoma and closed angle glaucoma. As per International Council of Ophthalmology report, closed angle and open angle glaucoma individually account for about half of all glaucoma cases and are the major cause of irreversible vision globally. For glaucoma, everyone is at risk from babies to senior citizens. The market for glaucoma treatment has been growing rapidly since last few years due to increasing number of people with glaucoma and introduction of innovative treatments. In past few years different therapies are introduced including, laser therapy, photodynamic therapy, IOPtiMa therapy along with eye drops and pills which will grow the glaucoma treatment market in coming years.
The driver of glaucoma treatment market includes rising geriatric population and healthcare expenditure. It has been stated that glaucoma is more prevalent among the people above age of 60 and globally growing geriatric population is expected as the main reason for growth of glaucoma treatment market in forecast period of 2016-2024. Cases of congenital glaucoma are increasing and main reason for this problem is changing lifestyle and habits. According to Glaucoma Research Foundation survey, approximately one out of 10,000 babies born with glaucoma in United States. Improved medical coverage and new innovation in glaucoma drugs and treatments are also the key factors which are expected to drive the growth of glaucoma treatment market.
Global glaucoma treatment market is segmented on the basis of drug class, therapy used, disease indication, end users and region. Based on drug class, glaucoma treatment market further segmented into Prostaglandin Analogs (PGAs), Alpha Agonist, Beta Blockers, Cholinergic, Carbonic Anhydrase Inhibitors, and Combined Medications. Prostaglandin Analogs drug segment is expected to account for the largest share of the global glaucoma treatment market as new innovative drugs are coming are in this segment also on the basis of treatment, also these drugs are widely prescribed drugs.
In the basis of therapy, glaucoma treatment market is further segmented into Glaucoma surgery, Laser iridotomy, Laser trabeculoplasty, Aqueous shunt surgery and Peripheral iridectomy. Glaucoma surgery segment is expected to have highest share of glaucoma treatment market. Increasing geriatric population and trust buildup on surgery treatment as compared to laser treatments are the factors contributing towards the growth of this segment in glaucoma treatment market in coming years.
Browse Global Strategic Business Report: http://www.transparencymarketresearch.com/glaucoma-treatment-market.html
On the basis of disease indication, glaucoma treatment market is further segmented into angle closure glaucoma (ACG), open angle glaucoma (OAG), secondary glaucoma, congenital glaucoma and other. Other less common types of glaucoma includes pigmentary glaucoma, pseudoexfoliation glaucoma and normal-tension glaucoma (NTG). The most common types of glaucoma are open angle glaucoma (OAG) and closed angle glaucoma (CAG). As per International Council of Ophthalmology report, closed angle and open angle glaucoma individually account for about half of all glaucoma cases also they are responsible for the major cause of irreversible vision worldwide. Therefore, Open angle glaucoma and angle closure glaucoma segments are expected to account for highest share of glaucoma treatment market in the forecast period of 2016-2024. On the basis of end users, glaucoma treatment market is segmented into hospitals, specialized clinics, ambulatory surgery centers, hospital pharmacies, drug stores and retail pharmacies.
Geographically, the global glaucoma treatment market is divided into five key regions, North America, Europe, Asia-Pacific, Latin America and the Middle East, and Africa. In terms of geography, North America is expected to account for the extensive market share for glaucoma treatment market where the number of glaucoma patients is the highest. Moreover, the Asian market is expected to become a huge potential market for glaucoma treatment in the forecast period, as it is expected to grow at fastest CAGR among all other regions.
Major players in glaucoma treatment market includes Novartis AG, Allergan, Merck & Co., Inc., Akorn, Inc., Bausch & Lomb Incorporated, Teva Pharmaceuticals, Pfizer and Santen.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Download Exclusive Brochure of This Report :
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453